Matches in SemOpenAlex for { <https://semopenalex.org/work/W2557585974> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W2557585974 abstract "Abstract Background: Ticlopidine and clopidogrel, thienopyridine derivatives used for cerebrovascular events and coronary artery syndromes, are the first and third most common causes of drug-related TTP reported to the FDA. Ticlopine-associated TTP has been characterized as having later onset, having higher relapse rates, and being more responsive to plasmapheresis—findings associated with ADAMTS13-deficiency. Based on a limited number of ADAMTS13 measurements, Moake (NEJM 2002) and Bennett (NEJM 2000) speculated that antibody-mediated ADAMTS13-deficiency appeared to be the cause of both ticlopidine- and clopidogrel-associated TTP. Methods: Clinical and ADAMTS13 laboratory data for TTP associated with ticlopidine (n=116 and 12 cases, respectively) and clopidogrel (n= 46 and 7 cases, respectively) were reviewed. Results: Clinical Evaluation: Mortality of ticlopidine-associated TTP was 34.5%. Mortality of clopidogrel-associated TTP was 22.2%. Overall moretlaity rate was 31%. Among 162 thienopyridine-associated TTP cases, late-onset TTP (89% of the cases) occurred after > 5 days of thienopyridine use and was 4-times more common with ticlopidine than clopidogrel. Early onset TTP (11% of the cases) occurred within 5-days of thienopyridine initiation and was 4-times less common with ticlopidine than clopidogrel. Laboratory Evaluation: Among 12-ticlopidine and 7-clopidogrel-associated TTP patients, laboratory assays prior to plasmapheresis identified severe ADAMTS13 deficiency 3.3-fold more often with ticlopidine (92% versus 29%, p < 0.01) and presence of inhibitory autoantibody almost 3-fold more common with ticlopidine (83% vs 30%) than clopidogrel. Among thienopyridine-associated TTP cases, patients with severe ADAMTS13-deficiency (<5% of normal) experienced higher relapses rates (15% versus 0%). Conclusions: Contrary to previously proposed mechanistic hypotheses, thienopyridine-associated TTP appears to manifest as an ADAMTS13-deficiency mediated syndrome (primarily with > 5 days of ticlopidine) that has occasional relapses and an ADAMTS13-normal syndrome (primarily with < 5 days of clopidogrel) that is not associated with relapse. Although in the same drug class, the metabolites of ticlopidine and clopidogrel are different, which may account for the distinct mechanistic pathways. Immunologically mediated ADAMTS13 -deficient TTP, like ticlopidine-associated TTP, may result from immunogenic exposures that occurred 1 to 2 weeks prior to syndrome onset. In contrast, ADAMTS13-normal TTP cases, like clopidogrel-associated TTP, may result from recent exposure that occurred within 5 days prior to TTP onset leading to direct endothelial cell injury." @default.
- W2557585974 created "2016-12-08" @default.
- W2557585974 creator A5020210546 @default.
- W2557585974 creator A5037456539 @default.
- W2557585974 creator A5044785780 @default.
- W2557585974 creator A5052537687 @default.
- W2557585974 creator A5058322630 @default.
- W2557585974 creator A5061766064 @default.
- W2557585974 creator A5063153537 @default.
- W2557585974 creator A5063490330 @default.
- W2557585974 creator A5066491106 @default.
- W2557585974 creator A5067434226 @default.
- W2557585974 creator A5068499084 @default.
- W2557585974 creator A5069161010 @default.
- W2557585974 date "2005-11-16" @default.
- W2557585974 modified "2023-09-28" @default.
- W2557585974 title "ADAMTS13 Levels Support Hypothesis of Distinct Mechanistic Pathways for Early Versus Late-Onset of Thienopyridine-Associated Thrombotic Thrombocytopenic Purpura (TTP)." @default.
- W2557585974 doi "https://doi.org/10.1182/blood.v106.11.60.60" @default.
- W2557585974 hasPublicationYear "2005" @default.
- W2557585974 type Work @default.
- W2557585974 sameAs 2557585974 @default.
- W2557585974 citedByCount "0" @default.
- W2557585974 crossrefType "journal-article" @default.
- W2557585974 hasAuthorship W2557585974A5020210546 @default.
- W2557585974 hasAuthorship W2557585974A5037456539 @default.
- W2557585974 hasAuthorship W2557585974A5044785780 @default.
- W2557585974 hasAuthorship W2557585974A5052537687 @default.
- W2557585974 hasAuthorship W2557585974A5058322630 @default.
- W2557585974 hasAuthorship W2557585974A5061766064 @default.
- W2557585974 hasAuthorship W2557585974A5063153537 @default.
- W2557585974 hasAuthorship W2557585974A5063490330 @default.
- W2557585974 hasAuthorship W2557585974A5066491106 @default.
- W2557585974 hasAuthorship W2557585974A5067434226 @default.
- W2557585974 hasAuthorship W2557585974A5068499084 @default.
- W2557585974 hasAuthorship W2557585974A5069161010 @default.
- W2557585974 hasConcept C126322002 @default.
- W2557585974 hasConcept C141071460 @default.
- W2557585974 hasConcept C164705383 @default.
- W2557585974 hasConcept C2777628954 @default.
- W2557585974 hasConcept C2777849778 @default.
- W2557585974 hasConcept C2778585876 @default.
- W2557585974 hasConcept C2778905298 @default.
- W2557585974 hasConcept C2779837110 @default.
- W2557585974 hasConcept C2780921031 @default.
- W2557585974 hasConcept C71924100 @default.
- W2557585974 hasConcept C89560881 @default.
- W2557585974 hasConcept C90924648 @default.
- W2557585974 hasConceptScore W2557585974C126322002 @default.
- W2557585974 hasConceptScore W2557585974C141071460 @default.
- W2557585974 hasConceptScore W2557585974C164705383 @default.
- W2557585974 hasConceptScore W2557585974C2777628954 @default.
- W2557585974 hasConceptScore W2557585974C2777849778 @default.
- W2557585974 hasConceptScore W2557585974C2778585876 @default.
- W2557585974 hasConceptScore W2557585974C2778905298 @default.
- W2557585974 hasConceptScore W2557585974C2779837110 @default.
- W2557585974 hasConceptScore W2557585974C2780921031 @default.
- W2557585974 hasConceptScore W2557585974C71924100 @default.
- W2557585974 hasConceptScore W2557585974C89560881 @default.
- W2557585974 hasConceptScore W2557585974C90924648 @default.
- W2557585974 hasLocation W25575859741 @default.
- W2557585974 hasOpenAccess W2557585974 @default.
- W2557585974 hasPrimaryLocation W25575859741 @default.
- W2557585974 hasRelatedWork W1530308945 @default.
- W2557585974 hasRelatedWork W2047447624 @default.
- W2557585974 hasRelatedWork W2054516341 @default.
- W2557585974 hasRelatedWork W2085817407 @default.
- W2557585974 hasRelatedWork W2317139162 @default.
- W2557585974 hasRelatedWork W2557585974 @default.
- W2557585974 hasRelatedWork W2557785950 @default.
- W2557585974 hasRelatedWork W2564074605 @default.
- W2557585974 hasRelatedWork W2568477395 @default.
- W2557585974 hasRelatedWork W2586244725 @default.
- W2557585974 isParatext "false" @default.
- W2557585974 isRetracted "false" @default.
- W2557585974 magId "2557585974" @default.
- W2557585974 workType "article" @default.